Emerging Role of Organ‐on‐a‐Chip Technologies in Quantitative Clinical Pharmacology Evaluation

The recently enacted Prescription Drug User Fee Act (PDUFA) VI includes in its performance goals “enhancing regulatory science and expediting drug development.” The key elements in “enhancing regulatory decision tools to support drug development and review” include “advancing model‐informed drug dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Isoherranen, Nina, Madabushi, Rajanikanth, Huang, Shiew‐Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440571/
https://www.ncbi.nlm.nih.gov/pubmed/30740886
http://dx.doi.org/10.1111/cts.12627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440571/
https://www.ncbi.nlm.nih.gov/pubmed/30740886
http://dx.doi.org/10.1111/cts.12627

Ejemplares similares